Concept information
Preferred term
NVX-CoV2373
Definition
- NVX-CoV2373 is a full length recombinant SARS CoV-2 glycoprotein nanoparticle vaccine. Haute Autorité de Santé. "Strategie de vaccination contre le SARS-CoV-2.". (Retrieved 08/12/2020, from https://www.has-sante.fr/ )
Broader concept
Entry terms
- Full length recombinant SARS CoV-2 gly-coprotein nanoparticle vaccine
- SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Creator
- Patricia Fener
In other languages
-
French
URI
http://data.loterre.fr/ark:/67375/C0X-BGVB935B-4
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}